Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant - Image 1

£105.41

Wiley-Blackwell Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant

Name: Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant
Brand: Wiley-Blackwell
Price: 104.23 GBP
Availability: InStock

9781119612698

General Practice

Price History & Forecast

Last 87 days • 87 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 87 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £102 (22 days, 25.3%)

Price range: £97 - £105

Price levels: 7 different prices over 87 days

Description

Blood and Marrow Transplantation Long Term Management Hematopoietic cell transplantation (HCT) provides curative therapy for a variety of diseases. Over the past several decades, significant advances have been made in the field of HCT, to the point where HCT has become an integral part of treatment modality for a variety of hematologic malignancies and some nonmalignant diseases. HCT remains an important treatment option for a wide variety of hematologic and nonhematologic disorders, despite recent advances in the field of immunologic therapies. Factors driving this growth include expanded disease indications, greater donor options (expanding unrelated donor registries and haploidentical HCT), and accommodation of older and less fit recipients. The development of less toxic pretransplant conditioning regimens, more effective prophylaxis of graft-versus-host disease (GVHD), improved infection control, and other advances in transplant technology have resulted in a rapidly growing number of transplant recipients surviving long-term free of the disease for which they were transplanted. The changes over decades in the transplant recipient population and in the practice of HCT will have almost inevitably altered the composition of the long-term survivor population over time. Apart from an increasingly older transplant recipient cohort, the pattern of transplant indications has shifted from the 1990s when chronic myeloid leukemia made up a significant proportion of allo-HCT indications. Changes in cell source, donor types, conditioning regimens, GVHD prophylaxis, and supportive care have all occurred, with ongoing reductions in both relapse and non-relapse mortality (NRM) have been demonstrated. These patients have increased risks for a variety of late complications, which can cause morbidity and mortality. Most long-term survivors return to the care of their local hematologists/oncologists or primary care physicians, who may not be familiar with specialized monitoring and management of long complications after HCT for this patient population. As HCT survivorship increases, the focus of care has shifted to the identification and treatment of long-term complications that may affect quality of life and long-term morbidity and mortality. Preventive care as well as early detection and treatments are important aspects to reducing morbidity and mortality in long-term survivors after allo-HCT. This second edition, Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant, provides up-to-date information about diagnosis, screening, treatment, and long-term surveillance of long-term survivors after HCT.

Product Specifications

Brand: Wiley-Blackwell
Model: 9781119612698
Format: hardcover
ASIN: 1119612691
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > General Practice
Domain: Amazon UK
Release Date: 03 June 2021
Listed Since: 28 November 2020

Barcode

No barcode data available

Wiley-Blackwell Blood and Marrow Transplantation Long Term Management: Survivorship after Transplant

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Blood Stem Cell Transplantation: 77 (Cancer Treatment and Research, 77)

Manual of Hematopoietic Cell Transplantation and Cellular Therapies

CRC Press Hematopoietic Stem Cell Transplantation Book

Contemporary Bone Marrow Transplantation (Organ and Tissue Transplantation)

Cord Blood Transplantations (Advances and Controversies in Hematopoietic Transplantation and Cell Therapy)

Biology and Treatment of Leukemia and Bone Marrow Neoplasms: 181 (Cancer Treatment and Research, 181)

Clinical Manual of Blood and Bone Marrow Transplantation

Springer Supportive Care Strategies: Optimizing Transplant Care

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation: Models in Discovery and Translation

Hematology: Basic Principles and Practice

Bone Marrow Transplantation Across Major Genetic Barriers

Blood Stem Cell Transplantation: 77 (Cancer Treatment and Research, 77)

Bone Marrow Transplantation: 50 (Cancer Treatment and Research, 50)

Bone Marrow Transplantation: 50 (Cancer Treatment and Research, 50)

A Guide to Bone Marrow Transplantation

Hematopoietic Stem Cell Transplantation (Contemporary Hematology)

Hematopoietic Stem Cell Transplantation (Contemporary Hematology)

Hematopoietic Growth Factors in Oncology: 157 (Cancer Treatment and Research, 157)

Springer - Transplantation in Hematology and Oncology II

Springer - Transplantation in Hematology and Oncology II

Hematologic Malignancies: An Overview - Hematology Research

Wintrobe's Clinical Hematology: Print + eBook with Multimedia: 1-2

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation: Models in Discovery and Translation

Advances in Allogeneic Hematopoietic Stem Cell Transplantation: 101 (Cancer Treatment and Research, 101)